Literature DB >> 22834859

Class 3 semaphorins as a therapeutic target.

Yoshio Goshima1, Yukio Sasaki, Naoya Yamashita, Fumio Nakamura.   

Abstract

INTRODUCTION: The semaphorins were initially described as axon guidance molecules that play important roles in the development of nervous system. Recent studies suggest that semaphorins and their receptors also exert such diverse functions as immune response, control of vascular endothelial cell motility and invasion of many types of cancer cells. AREAS COVERED: The available results concerning application of class 3 semaphorins and their inhibitors for the treatment in animal disease models. EXPERT OPINION: Because semaphorins are now recognized as key players in immune, cardiovascular, bone metabolism and neurological system, semaphorins and their receptors are most promising therapeutic targets for various disease states. As semaphorins exert their diverse or even opposing activities in vivo, more elaborate studies on pathophysiology and signal transduction mechanisms of semaphorins are required.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22834859     DOI: 10.1517/14728222.2012.710201

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  7 in total

Review 1.  Semaphorins and plexins as therapeutic targets.

Authors:  Thomas Worzfeld; Stefan Offermanns
Journal:  Nat Rev Drug Discov       Date:  2014-08       Impact factor: 84.694

Review 2.  Immunological functions of the neuropilins and plexins as receptors for semaphorins.

Authors:  Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

3.  Significance of semaphorin-3A and MMP-14 protein expression in non-small cell lung cancer.

Authors:  Haiying Zhou; Aiping Wu; Wei Fu; Zheng Lv; Zhiyong Zhang
Journal:  Oncol Lett       Date:  2014-02-27       Impact factor: 2.967

4.  Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion.

Authors:  Rebecca Sorber; Yaroslav Teper; Abisola Abisoye-Ogunniyan; Joshua J Waterfall; Sean Davis; J Keith Killian; Marbin Pineda; Satyajit Ray; Matt R McCord; Holger Pflicke; Sandra Sczerba Burkett; Paul S Meltzer; Udo Rudloff
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

5.  Semaphorin 3A attenuates cardiac autonomic disorders and reduces inducible ventricular arrhythmias in rats with experimental myocardial infarction.

Authors:  Hesheng Hu; Yongli Xuan; Mei Xue; Wenjuan Cheng; Ye Wang; Xinran Li; Jie Yin; Xiaolu Li; Na Yang; Yugen Shi; Suhua Yan
Journal:  BMC Cardiovasc Disord       Date:  2016-01-19       Impact factor: 2.298

6.  Wedelolactone Enhances Osteoblastogenesis but Inhibits Osteoclastogenesis through Sema3A/NRP1/PlexinA1 Pathway.

Authors:  Yan-Qiu Liu; Xiao-Fei Han; Jun-Xia Bo; Hui-Peng Ma
Journal:  Front Pharmacol       Date:  2016-10-18       Impact factor: 5.810

7.  Mutational spectrum of semaphorin 3A and semaphorin 3D genes in Spanish Hirschsprung patients.

Authors:  Berta Luzón-Toro; Raquel M Fernández; Ana Torroglosa; Juan Carlos de Agustín; Cristina Méndez-Vidal; Dolores Isabel Segura; Guillermo Antiñolo; Salud Borrego
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.